BOSTON, Feb. 23, 2022 /PRNewswire/ -- Haemonetics Corporation /zigman2/quotes/205816408/composite HAE +3.90% announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022, at 9:50 a.m. ET.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at: https://kvgo.com/rj-43rd-iic/haemonetics-corporation-march-2022
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for one year on Haemonetics' Investor Relations website.
Haemonetics /zigman2/quotes/205816408/composite HAE +3.90% is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .
|Investor Contact:||Media Contact:|
|Olga Guyette, Director-Investor Relations||Josh Gitelson, Director-Global Communications|
|(781) 356-9763||(781) 356-9776|
View original content to download multimedia: https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-43rd-annual-institutional-investors-conference-301488959.html
SOURCE Haemonetics Corporation
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.
Copyright (C) 2022 PR Newswire. All rights reserved